D-0841-2016 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0841-2016 was initiated by Dr. Reddy's Laboratories, Inc. on Mar 30, 2016 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; 12 month stability time point The recall status is terminated (terminated Apr 10, 2017). Affected quantity: 50,280 bottles.

Recall details

Product Type
Drugs
Report Date
May 18, 2016
Initiation Date
Mar 30, 2016
Termination Date
Apr 10, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
50,280 bottles

Product description

Ondansetron Tablets USP, 4 mg, 30 count bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories, Bachupally, India --- NDC 56111-153-30

Reason for recall

Failed Impurities/Degradation Specifications; 12 month stability time point

Distribution pattern

Nationwide

Code information

Lot number C500691, exp 12/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0841-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0841-2016. Report a data issue: hello@regdatalab.com.